Skip to main content

Renew Phase

CJC-1295 (NO-DAC) 10mg

CJC-1295 (No DAC), commonly associated with Modified GRF (1-29) in research-product labeling, is a synthetic 29-amino-acid peptide analog related to growth hormone-releasing hormone research. Unlike DAC-conjugated CJC-1295, this form does not contain the Drug Affinity Complex modification.

It is supplied exclusively for controlled in-vitro laboratory research and analytical characterization by qualified professionals.

CAS#: 86168-78-7
Formula: C₁₄₉H₂₄₆N₄₄O₄₂
M.W: 3357.87 g/mol

$ 50

Long Description

Product Name:

CJC-1295 (NO DAC)

Chemical Information:

  • Common Research Designation: CJC-1295 No DAC / Modified GRF (1-29)
  • Peptide Length: 29 amino acids
  • Structural Type: Modified GHRH-related peptide analog
  • DAC Modification: None
  • Molecular Weight: Approximately 3.36 kDa, depending on exact molecular and salt form
  • Compound Class: Synthetic modified peptide

Product Description:

CJC-1295 (No DAC) is a synthetic research peptide consisting of a modified 29-residue sequence related to growth hormone-releasing hormone. The absence of a Drug Affinity Complex distinguishes this material from CJC-1295 preparations containing DAC and is an important structural consideration during analytical characterization. Researchers may examine the peptide using chromatographic, spectrometric, and other validated analytical techniques to evaluate identity, purity, molecular stability, and structural consistency. The exact formula and molecular mass can vary by peptide form, counterion, and supplier documentation. This material is intended strictly for in-vitro laboratory research and analytical applications.

Research Applications:

  • Analytical characterization of modified 29-residue peptide sequences
  • Comparative studies of DAC and non-DAC peptide configurations
  • In-vitro investigation of peptide-receptor interaction models
  • Chromatographic and mass-spectrometric method development
  • Stability and degradation studies under controlled laboratory conditions

Storage and Handling:

  • Store according to requirements stated on the product label or Certificate of Analysis
  • Protect from excessive heat, direct light, and moisture
  • Keep the container securely sealed between laboratory uses
  • Avoid unnecessary temperature fluctuations
  • Use appropriate laboratory handling and contamination-control procedures

Product Specifications:

  • Purity: Confirm through batch-specific Certificate of Analysis
  • Appearance: Typically supplied as a solid or lyophilized research material
  • Peptide Length: 29 amino acids
  • Modification: No Drug Affinity Complex
  • Molecular Weight: Approximately 3.36 kDa, depending on supplied form
  • Documentation: Final structural specifications should be verified through batch-specific analytical records

Compliance Notice:

CJC-1295 (NO DAC) is FOR RESEARCH USE ONLY. It is not intended for human or veterinary use. It is not intended to diagnose, treat, cure, or prevent any disease. This material is supplied solely for controlled in-vitro laboratory investigation. Purchasers are responsible for proper storage, handling, and use in accordance with applicable requirements.

Description

Product Name:

CJC-1295 (NO DAC)

Chemical Information:

  • Common Research Designation: CJC-1295 No DAC / Modified GRF (1-29)
  • Peptide Length: 29 amino acids
  • Structural Type: Modified GHRH-related peptide analog
  • DAC Modification: None
  • Molecular Weight: Approximately 3.36 kDa, depending on exact molecular and salt form
  • Compound Class: Synthetic modified peptide

Product Description:

CJC-1295 (No DAC) is a synthetic research peptide consisting of a modified 29-residue sequence related to growth hormone-releasing hormone. The absence of a Drug Affinity Complex distinguishes this material from CJC-1295 preparations containing DAC and is an important structural consideration during analytical characterization. Researchers may examine the peptide using chromatographic, spectrometric, and other validated analytical techniques to evaluate identity, purity, molecular stability, and structural consistency. The exact formula and molecular mass can vary by peptide form, counterion, and supplier documentation. This material is intended strictly for in-vitro laboratory research and analytical applications.

Research Applications:

  • Analytical characterization of modified 29-residue peptide sequences
  • Comparative studies of DAC and non-DAC peptide configurations
  • In-vitro investigation of peptide-receptor interaction models
  • Chromatographic and mass-spectrometric method development
  • Stability and degradation studies under controlled laboratory conditions

Storage and Handling:

  • Store according to requirements stated on the product label or Certificate of Analysis
  • Protect from excessive heat, direct light, and moisture
  • Keep the container securely sealed between laboratory uses
  • Avoid unnecessary temperature fluctuations
  • Use appropriate laboratory handling and contamination-control procedures

Product Specifications:

  • Purity: Confirm through batch-specific Certificate of Analysis
  • Appearance: Typically supplied as a solid or lyophilized research material
  • Peptide Length: 29 amino acids
  • Modification: No Drug Affinity Complex
  • Molecular Weight: Approximately 3.36 kDa, depending on supplied form
  • Documentation: Final structural specifications should be verified through batch-specific analytical records

Compliance Notice:

CJC-1295 (NO DAC) is FOR RESEARCH USE ONLY. It is not intended for human or veterinary use. It is not intended to diagnose, treat, cure, or prevent any disease. This material is supplied solely for controlled in-vitro laboratory investigation. Purchasers are responsible for proper storage, handling, and use in accordance with applicable requirements.

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 (NO-DAC) 10mg”

Your email address will not be published. Required fields are marked *

Related Products